Financials
- Market Capitalization 36.3476 M
- Employee 89
- Founded 2012
- CEO N/A
- Website www.omniab.com
- Headquarter Delaware, United States
- FIGI BBG012QXTPF0
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.21
Relación precio/flujo de caja
0.24
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4338 | CRVO CervoMed Inc. - Common Stock | 2.63 USD | 0.00% | -0.75% | +1.15% | -72.75% | 39.76 M USD | ||
| 4377 | RNAZ TransCode Therapeutics, Inc. - Common Stock | 2.16 USD | +2.86% | -17.24% | -52.21% | -77.28% | 36.57 M USD | ||
| 4380 | ALGS Aligos Therapeutics, Inc. - Common stock | 5.80 USD | -1.02% | -20.33% | +35.20% | -40.76% | 36.17 M USD | ||
| 4389 | ACTU Actuate Therapeutics, Inc. - Common stock | 1.46 USD | -3.95% | -0.68% | +28.07% | -64.22% | 35.06 M USD |